Jeremy P. Springhorn's most recent trade in uniQure N.V. was a trade of 15,840 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 19, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
uniQure N.V. | Jeremy P. Springhorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 15,840 | 15,840 | - | - | Stock Option (Right to Buy) | |
uniQure N.V. | Jeremy P. Springhorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 8,080 | 31,836 (0%) | 0% | 0 | Ordinary Shares | |
uniQure N.V. | Jeremy P. Springhorn | Director | Sale of securities on an exchange or to another person at price $ 5.12 per share. | 13 Jun 2024 | 2,231 | 23,756 (0%) | 0% | 5.1 | 11,423 | Ordinary Shares |
uniQure N.V. | Jeremy P. Springhorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 17,060 | 17,060 | - | - | Stock Option (Right to Buy) | |
uniQure N.V. | Jeremy P. Springhorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 8,700 | 28,273 (0%) | 0% | 0 | Ordinary Shares | |
uniQure N.V. | Jeremy P. Springhorn | Director | Sale of securities on an exchange or to another person at price $ 18.88 per share. | 13 Jun 2023 | 2,286 | 25,987 (0%) | 0% | 18.9 | 43,160 | Ordinary Shares |
uniQure N.V. | Jeremy P. Springhorn | Director | Sale of securities on an exchange or to another person at price $ 20.41 per share. | 27 Feb 2023 | 384 | 19,573 (0%) | 0% | 20.4 | 7,837 | Ordinary Shares |
uniQure N.V. | Jeremy P. Springhorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 17,810 | 17,810 | - | - | Stock Option (Right to Buy) | |
uniQure N.V. | Jeremy P. Springhorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 9,080 | 19,957 (0%) | 0% | 0 | Ordinary Shares | |
uniQure N.V. | Jeremy P. Springhorn | Director | Sale of securities on an exchange or to another person at price $ 16.70 per share. | 28 Feb 2022 | 602 | 10,877 (0%) | 0% | 16.7 | 10,053 | Ordinary Shares |
uniQure N.V. | Jeremy P. Springhorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 2,645 | 2,645 | - | - | Stock Option (Right to Buy) | |
uniQure N.V. | Jeremy P. Springhorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 1,534 | 11,479 (0%) | 0% | 0 | Ordinary Shares | |
uniQure N.V. | Jeremy P. Springhorn | Director | Sale of securities on an exchange or to another person at price $ 37.50 per share. | 02 Mar 2021 | 505 | 9,945 (0%) | 0% | 37.5 | 18,938 | Ordinary Shares |
uniQure N.V. | Jeremy P. Springhorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 4,107 | 4,107 | - | - | Stock Option (Right to Buy) | |
uniQure N.V. | Jeremy P. Springhorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 2,382 | 10,450 (0%) | 0% | 0 | Ordinary Shares | |
Syros Pharmaceuticals Inc. | Jeremy P. Springhorn | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 94,000 | 94,000 | - | - | Stock Option (right to buy) |